These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29279275)

  • 1. A convenient transesterification method for synthesis of AT2 receptor ligands with improved stability in human liver microsomes.
    Wannberg J; Isaksson R; Bremberg U; Backlund M; Sävmarker J; Hallberg M; Larhed M
    Bioorg Med Chem Lett; 2018 Feb; 28(3):519-522. PubMed ID: 29279275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-(Methyloxycarbonyl)thiophene sulfonamides as high affinity AT2 receptor ligands.
    Wannberg J; Gising J; Lindman J; Salander J; Gutiérrez-de-Terán H; Ablahad H; Hamid S; Grönbladh A; Spizzo I; Gaspari TA; Widdop RE; Hallberg A; Backlund M; Leśniak A; Hallberg M; Larhed M
    Bioorg Med Chem; 2021 Jan; 29():115859. PubMed ID: 33309749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-(Heteroaryl)thiophene sulfonamides as angiotensin AT2 receptor ligands.
    Wannberg J; Gising J; Henriksson M; Vo DD; Sävmarker J; Sallander J; Gutiérrez-de-Terán H; Larsson J; Hamid S; Ablahad H; Spizzo I; Gaspari TA; Widdop RE; Grönbladh A; Petersen NN; Backlund M; Hallberg M; Larhed M
    Eur J Med Chem; 2024 Feb; 265():116122. PubMed ID: 38199164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Alkyl substituted benzimidazoles as a new class of selective AT2 receptor ligands.
    Roy T; Petersen NN; Gopalan G; Gising J; Hallberg M; Larhed M
    Bioorg Med Chem; 2022 Jul; 66():116804. PubMed ID: 35576659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II AT2 receptor ligands with phenylthiazole scaffolds.
    Gopalan G; Palo-Nieto C; Petersen NN; Hallberg M; Larhed M
    Bioorg Med Chem; 2022 Jul; 65():116790. PubMed ID: 35550979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Series of Analogues to the AT
    Isaksson R; Lindman J; Wannberg J; Sallander J; Backlund M; Baraldi D; Widdop R; Hallberg M; Åqvist J; Gutierrez de Teran H; Gising J; Larhed M
    ChemistryOpen; 2019 Jan; 8(1):114-125. PubMed ID: 30697513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin Peptides as AT2 Receptor Agonists.
    Hallberg M; Sävmarker J; Hallberg A
    Curr Protein Pept Sci; 2017; 18(8):809-818. PubMed ID: 28164758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative functional properties of two structurally similar selective nonpeptide drug-like ligands for the angiotensin II type-2 (AT(2)) receptor. Effects on neurite outgrowth in NG108-15 cells.
    Guimond MO; Wallinder C; Alterman M; Hallberg A; Gallo-Payet N
    Eur J Pharmacol; 2013 Jan; 699(1-3):160-71. PubMed ID: 23211679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors.
    Bosnyak S; Jones ES; Christopoulos A; Aguilar MI; Thomas WG; Widdop RE
    Clin Sci (Lond); 2011 Oct; 121(7):297-303. PubMed ID: 21542804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using conformational constraints at position 6 of Angiotensin II to generate compounds with enhanced AT2R selectivity and proteolytic stability.
    Tourwé D; Tsiailanis AD; Parisis N; Hirmiz B; Del Borgo M; Aguilar MI; Van der Poorten O; Ballet S; Widdop RE; Tzakos AG
    Bioorg Med Chem Lett; 2021 Jul; 43():128086. PubMed ID: 33965531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel potent and efficacious nonpeptidic urotensin II receptor agonists.
    Lehmann F; Pettersen A; Currier EA; Sherbukhin V; Olsson R; Hacksell U; Luthman K
    J Med Chem; 2006 Apr; 49(7):2232-40. PubMed ID: 16570919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From the first selective non-peptide AT(2) receptor agonist to structurally related antagonists.
    Murugaiah AM; Wu X; Wallinder C; Mahalingam AK; Wan Y; Sköld C; Botros M; Guimond MO; Joshi A; Nyberg F; Gallo-Payet N; Hallberg A; Alterman M
    J Med Chem; 2012 Mar; 55(5):2265-78. PubMed ID: 22248302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective angiotensin II AT2 receptor agonists: arylbenzylimidazole structure-activity relationships.
    Wu X; Wan Y; Mahalingam AK; Murugaiah AM; Plouffe B; Botros M; Karlén A; Hallberg M; Gallo-Payet N; Alterman M
    J Med Chem; 2006 Nov; 49(24):7160-8. PubMed ID: 17125268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and optimization of a novel series of indoleamine 2,3-dioxygenase inhibitors.
    Markwalder JA; Seitz SP; Blat Y; Elkin L; Hunt JT; Pabalan JG; Jure-Kunkel MN; Vite GD; Covello K
    Bioorg Med Chem Lett; 2017 Feb; 27(3):582-585. PubMed ID: 28003141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and structure-activity relationships of novel insulin receptor tyrosine kinase activators.
    Lum RT; Cheng M; Cristobal CP; Goldfine ID; Evans JL; Keck JG; Macsata RW; Manchem VP; Matsumoto Y; Park SJ; Rao SS; Robinson L; Shi S; Spevak WR; Schow SR
    J Med Chem; 2008 Oct; 51(19):6173-87. PubMed ID: 18788731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of the metabolic stability of a fluorinated cannabinoid receptor subtype 2 (CB
    Heimann D; Börgel F; de Vries H; Patberg M; Jan-Smith E; Frehland B; Schepmann D; Heitman LH; Wünsch B
    Eur J Med Chem; 2018 Feb; 146():409-422. PubMed ID: 29407967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and solid-phase purification of anthranilic sulfonamides as CCK-2 ligands.
    Woods CR; Hack MD; Allison BD; Phuong VK; Rosen MD; Morton MF; Prendergast CE; Barrett TD; Shankley NP; Rabinowitz MH
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6905-9. PubMed ID: 18029172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Pro7Ang III is a novel highly selective angiotensin II type 2 receptor (AT2R) agonist, which acts as a vasodepressor agent via the AT2R in conscious spontaneously hypertensive rats.
    Del Borgo M; Wang Y; Bosnyak S; Khan M; Walters P; Spizzo I; Perlmutter P; Hilliard L; Denton K; Aguilar MI; Widdop RE; Jones ES
    Clin Sci (Lond); 2015 Sep; 129(6):505-13. PubMed ID: 26186568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, structure-property relationships and pharmacokinetic evaluation of ethyl 6-aminonicotinate sulfonylureas as antagonists of the P2Y₁₂ receptor.
    Bach P; Boström J; Brickmann K; van Giezen JJ; Groneberg RD; Harvey DM; O'Sullivan M; Zetterberg F
    Eur J Med Chem; 2013 Jul; 65():360-75. PubMed ID: 23747805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.